Zoonotic & Vector-Borne Diseases

>

Latest News

FDA and CDC Recommend Pause on Chikungunya Vaccine IXCHIQ for Adults 65 and Older
FDA and CDC Recommend Pause on Chikungunya Vaccine IXCHIQ for Adults 65 and Older

May 12th 2025

Regulatory action follows reports of serious adverse events during use in elderly individuals; vaccine remains authorized for younger age groups in the US and Europe with over 40,000 doses administered globally.

Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics
Clinical Strategies for Tick Season: Lyme Prevention and Next-Gen Diagnostics

May 9th 2025

Single, Low Dose Primaquine Safely Blocks Malaria Transmission
Single, Low Dose Primaquine Safely Blocks Malaria Transmission

May 6th 2025

Pneumonia Antibiotic Cures Lyme Disease at Doses 100 Times Lower Than Standard Treatment
Pneumonia Antibiotic Cures Lyme Disease at Doses 100 Times Lower Than Standard Treatment

April 29th 2025

Discovery of PfAnchor Reveals New Vulnerability in Malaria Parasite’s Survival Mechanism
Discovery of PfAnchor Reveals New Vulnerability in Malaria Parasite’s Survival Mechanism

April 17th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.